The recent challenges in global supply have highlighted the value of securing critical medications like Ivermectin. Dependence on overseas manufacturers exposes nations to considerable vulnerabilities, including transportation delays, expense fluctuations, and even geopolitical concerns. Transitioning towards domestic sourcing of Ivermectin offers